Xylem Statistics
Total Valuation
Xylem has a market cap or net worth of $29.07 billion. The enterprise value is $30.18 billion.
| Market Cap | 29.07B |
| Enterprise Value | 30.18B |
Important Dates
The next confirmed earnings date is Tuesday, February 4, 2025, before market open.
| Earnings Date | Feb 4, 2025 |
| Ex-Dividend Date | Nov 26, 2024 |
Share Statistics
Xylem has 242.94 million shares outstanding. The number of shares has increased by 19.87% in one year.
| Current Share Class | 242.94M |
| Shares Outstanding | 242.94M |
| Shares Change (YoY) | +19.87% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 0.63% |
| Owned by Institutions (%) | 93.63% |
| Float | 241.16M |
Valuation Ratios
The trailing PE ratio is 35.02 and the forward PE ratio is 26.36. Xylem's PEG ratio is 2.07.
| PE Ratio | 35.02 |
| Forward PE | 26.36 |
| PS Ratio | 3.44 |
| Forward PS | 3.27 |
| PB Ratio | 2.74 |
| P/TBV Ratio | 43.13 |
| P/FCF Ratio | 35.11 |
| P/OCF Ratio | 25.43 |
| PEG Ratio | 2.07 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.87, with an EV/FCF ratio of 36.46.
| EV / Earnings | 36.37 |
| EV / Sales | 3.58 |
| EV / EBITDA | 17.87 |
| EV / EBIT | 26.66 |
| EV / FCF | 36.46 |
Financial Position
The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.20.
| Current Ratio | 1.96 |
| Quick Ratio | 1.31 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | 1.15 |
| Debt / FCF | 2.54 |
| Interest Coverage | 23.10 |
Financial Efficiency
Return on equity (ROE) is 8.08% and return on invested capital (ROIC) is 5.66%.
| Return on Equity (ROE) | 8.08% |
| Return on Assets (ROA) | 4.43% |
| Return on Capital (ROIC) | 5.66% |
| Revenue Per Employee | $366,261 |
| Profits Per Employee | $36,087 |
| Employee Count | 23,000 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 4.89 |
Taxes
In the past 12 months, Xylem has paid $92.00 million in taxes.
| Income Tax | 92.00M |
| Effective Tax Rate | 9.98% |
Stock Price Statistics
The stock price has increased by +7.84% in the last 52 weeks. The beta is 1.06, so Xylem's price volatility has been similar to the market average.
| Beta (5Y) | 1.06 |
| 52-Week Price Change | +7.84% |
| 50-Day Moving Average | 121.43 |
| 200-Day Moving Average | 131.25 |
| Relative Strength Index (RSI) | 53.53 |
| Average Volume (20 Days) | 1,208,083 |
Short Selling Information
The latest short interest is 3.64 million, so 1.50% of the outstanding shares have been sold short.
| Short Interest | 3.64M |
| Short Previous Month | 3.39M |
| Short % of Shares Out | 1.50% |
| Short % of Float | 1.51% |
| Short Ratio (days to cover) | 2.74 |
Income Statement
In the last 12 months, Xylem had revenue of $8.42 billion and earned $830.00 million in profits. Earnings per share was $3.42.
| Revenue | 8.42B |
| Gross Profit | 3.11B |
| Operating Income | 1.13B |
| Pretax Income | 838.00M |
| Net Income | 830.00M |
| EBITDA | 1.69B |
| EBIT | 1.13B |
| Earnings Per Share (EPS) | $3.42 |
Balance Sheet
The company has $989.00 million in cash and $2.10 billion in debt, giving a net cash position of -$1.11 billion or -$4.59 per share.
| Cash & Cash Equivalents | 989.00M |
| Total Debt | 2.10B |
| Net Cash | -1.11B |
| Net Cash Per Share | -$4.59 |
| Equity (Book Value) | 10.60B |
| Book Value Per Share | 43.59 |
| Working Capital | 1.96B |
Cash Flow
In the last 12 months, operating cash flow was $1.14 billion and capital expenditures -$315.00 million, giving a free cash flow of $828.00 million.
| Operating Cash Flow | 1.14B |
| Capital Expenditures | -315.00M |
| Free Cash Flow | 828.00M |
| FCF Per Share | $3.41 |
Margins
Gross margin is 36.93%, with operating and profit margins of 13.44% and 9.85%.
| Gross Margin | 36.93% |
| Operating Margin | 13.44% |
| Pretax Margin | 10.94% |
| Profit Margin | 9.85% |
| EBITDA Margin | 20.05% |
| EBIT Margin | 13.44% |
| FCF Margin | 9.83% |
Dividends & Yields
This stock pays an annual dividend of $1.44, which amounts to a dividend yield of 1.20%.
| Dividend Per Share | $1.44 |
| Dividend Yield | 1.20% |
| Dividend Growth (YoY) | 9.09% |
| Years of Dividend Growth | 13 |
| Payout Ratio | 42.14% |
| Buyback Yield | -19.87% |
| Shareholder Yield | -18.66% |
| Earnings Yield | 2.86% |
| FCF Yield | 2.85% |
Analyst Forecast
The average price target for Xylem is $152.10, which is 27.11% higher than the current price. The consensus rating is "Buy".
| Price Target | $152.10 |
| Price Target Difference | 27.11% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 7.33% |
| EPS Growth Forecast (5Y) | 17.70% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Xylem has an Altman Z-Score of 4.43 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.43 |
| Piotroski F-Score | 6 |